IAPCD - International Association for Pain and Chemical Dependency

Corporate Membership Information

The board of directors of the International Association for Pain and Chemical Dependency (IAPCD) is pleased to announce that it has voted in favor of establishing a category for corporate memberships beginning in 2008. Annual dues have been set at $3,500 per company. The board has also determined that appropriate recognition and privileges be extended to those organizations that support the association at this level. For more information see the 2008 Corporate Membership Prospectus.

IAPCD Welcomes its New Corporate Members
The IAPCD Board of Directors is pleased to announce that the following companies have become the first ever corporate members of the organization.

• Abbott Laboratories
• Alpharma Inc.
• Ameritox
• Cephalon, Inc.
• Dominion Diagnostics, LLC
• Grunenthal USA, Inc.
• King Pharmaceuticals, Inc.
• Neuromed Pharmaceuticals
• Pain Therapeutics, Inc.
• Purdue Pharma L.P.
• Seabrook House

Abbott is a global, broad-based healthcare company devoted to discovering new medicines, new technologies and new ways to manage health. Our products span the continuum of care, from nutritional products to medical devices and pharmaceutical therapies. Our comprehensive product line encircles life itself - addressing important health needs for all ages.

Alpharma Inc is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma has a growing branded pharmaceutical franchise in the U.S. pain market with KADIAN® (morphine sulfate extended-release) Capsules, and an innovative product pipeline that consists of several novel approaches to treat pain, including the FLECTOR® Patch (diclofenac epolamine topical patch). In addition, Alpharma is also internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.

Ameritox is the nation's leader in pain prescription monitoring. Only Ameritox offers RxGuardian, the most thorough and personalized lab report available. By comparing normalized values to established prescription-specific ranges, RxGuardian lets pain practitioners protect their patients by determining compliance based on prescription regimen.

Cephalon's Pain Care Franchise includes therapies for breakthrough pain and muscle spasms. FENTORA^® (fentanyl buccal tablet) [C-II] is indicated for breakthrough pain in opioid-tolerant patients with cancer. AMRIX^® (Cyclobenzaprine Hydrochloride Extended-Release Tablets), the only once-daily skeletal muscle relaxant, is indicated for muscle spasm associated with acute, painful musculoskeletal conditions.

Dominion Diagnostics is a fully certified national medical laboratory specializing in clinical quantitative urine drug testing, scientifically accurate medication monitoring, and fully integrated clinical support services. Dominion provides information regarding patient prescription adherence, illicit drug usage, addiction, and substance misuse for a diversity of medical specialties, including pain and addiction medicine.

Grunenthal GmbH is a leader in the field of pain therapy. In recognition of the problem of prescription opioid abuse, Grunenthal USA, Inc. has created a Center of Excellence for Abuse Liability committed to finding solutions to reduce prescription opioid abuse without negatively impacting product availability for legitimate pain patients.

King Pharmaceuticals, Inc. focuses on development, growth, and promotion of innovative and trusted medicines. Dedicated to improving and protecting quality of life for people around the world, King works diligently to successfully develop and deliver superior pharmaceutical products while operating in a socially responsible manner.

Neuromed Pharmaceuticals is a biopharmaceutical company developing and commercializing new and improved pain therapies. The company has a two pronged strategy to enhance the commercial attractiveness of existing pain therapies and develop small molecule pain drugs. We have three programs aimed at addressing this important unmet medical need.

Pain Therapeutics, Inc. is a biopharmaceutical company located near San Francisco, CA. We develop novel drugs for severe chronic pain, opioid dependency and oncology/hematology. In 2008 we expect to file a New Drug Application with the FDA for Remoxy^™, the only abuse-resistant oxycodone drug with published Phase III clinical data.

As a privately held pharmaceutical company founded by physicians, Purdue is focused on meeting the needs of healthcare providers and the patients in their care. We are committed to finding, developing, and bringing to market new medicines and related products that improve health outcomes.

Seabrook House is a private, nationally recognized, inpatient drug and alcohol treatment center located in rural Bridgeton, NJ, only 45 minutes from Philadelphia, PA. Our campus extends over a 40-acre manicured estate. For over 34 years we have been helping families find the courage from this disease. Licensed for 29 sub-acute detox beds and 96 residential rehab beds, we are CARF accredited with expertise in opioid detoxification. We now offer the Mater-Liber (Latin for mother/child) Program - the only short-term (45 days) primary treatment program in the country that allows a mother to bring her child with her into rehab.